Industrial PhD fellow
- Research & Development
- Denmark - Måløv
In this PhD project you will have the chance to start your scientific career in haemophilia research and thereby in the longer term positively impact the lives of people with haemophilia.
About the department
You will be located in the department of In Vivo Haemophilia Pharmacology at Novo Nordisk. Our main focus is state of the art in vivo effect models of haemophilia. We support the Novo Nordisk haemophilia portfolio as well as the global haemophilia society with basic and advanced pharmacology data and disease understanding. The department comprises four PhD’s with backgrounds in biology, human biology, pharmacy and veterinary medicine, six in vivo laboratory technicians, and a trainee.
The Job
Haemophilia A is a bleeding disorder caused lack of coagulation factor VIII (FVIII) in the blood. In haemophilia A, much research has gone into replacing the lacking FVIII. However, there may potentially also be a therapeutic benefit of pharmacologically inhibiting fibrinolysis, i.e. the process leading to clot resolution. There is still a significant lack of knowledge within this field and in this regard several relevant scientific questions can only be appropriately addressed in vivo. The PhD project will try to answer such questions in mouse and rat models of haemophilia.
In support of the project, a research collaboration between the University of Copenhagen, Children's Hospital Research Foundation at the University of Cincinnati College of Medicine, The University of North Carolina at Chapel Hill, and Novo Nordisk A/S is set up. Thus, you will have access to support from world-leading experts in the field.
As an industrial PhD fellow in In Vivo Haemophilia Pharmacology your key responsibility will be to drive the project forward. This primarily means planning and executing in vivo experiments. Additionally, the curriculum includes attending courses (30 ECTS) and giving scientific presentations internally as well as externally.
Qualifications
You hold an academic degree (MSc level) in veterinary medicine, medicine, human biology or similar with outstanding marks. Preferably, you have knowledge on haemostasis and hands on experience with in vivo research in rodents. You are a dedicated self-motivating team player with a high degree of flexibility and a strong personal drive. Fluency in written and spoken English is essential. The project includes a three month stay in the US for which you must be able to temporarily relocate.
At Novo Nordisk, we strive for excellence. As a world leader in diabetes care and a major player in haemostasis management, growth hormone therapy and hormone replacement therapy, we offer our employees opportunities for continuous growth.
Contact
For further information regarding the position, please contact Tom Knudsen at +45 3075 1869.
Deadline
7 December 2013
- Research & Development
- Denmark - Måløv
In this PhD project you will have the chance to start your scientific career in haemophilia research and thereby in the longer term positively impact the lives of people with haemophilia.
About the department
You will be located in the department of In Vivo Haemophilia Pharmacology at Novo Nordisk. Our main focus is state of the art in vivo effect models of haemophilia. We support the Novo Nordisk haemophilia portfolio as well as the global haemophilia society with basic and advanced pharmacology data and disease understanding. The department comprises four PhD’s with backgrounds in biology, human biology, pharmacy and veterinary medicine, six in vivo laboratory technicians, and a trainee.
The Job
Haemophilia A is a bleeding disorder caused lack of coagulation factor VIII (FVIII) in the blood. In haemophilia A, much research has gone into replacing the lacking FVIII. However, there may potentially also be a therapeutic benefit of pharmacologically inhibiting fibrinolysis, i.e. the process leading to clot resolution. There is still a significant lack of knowledge within this field and in this regard several relevant scientific questions can only be appropriately addressed in vivo. The PhD project will try to answer such questions in mouse and rat models of haemophilia.
In support of the project, a research collaboration between the University of Copenhagen, Children's Hospital Research Foundation at the University of Cincinnati College of Medicine, The University of North Carolina at Chapel Hill, and Novo Nordisk A/S is set up. Thus, you will have access to support from world-leading experts in the field.
As an industrial PhD fellow in In Vivo Haemophilia Pharmacology your key responsibility will be to drive the project forward. This primarily means planning and executing in vivo experiments. Additionally, the curriculum includes attending courses (30 ECTS) and giving scientific presentations internally as well as externally.
Qualifications
You hold an academic degree (MSc level) in veterinary medicine, medicine, human biology or similar with outstanding marks. Preferably, you have knowledge on haemostasis and hands on experience with in vivo research in rodents. You are a dedicated self-motivating team player with a high degree of flexibility and a strong personal drive. Fluency in written and spoken English is essential. The project includes a three month stay in the US for which you must be able to temporarily relocate.
At Novo Nordisk, we strive for excellence. As a world leader in diabetes care and a major player in haemostasis management, growth hormone therapy and hormone replacement therapy, we offer our employees opportunities for continuous growth.
Contact
For further information regarding the position, please contact Tom Knudsen at +45 3075 1869.
Deadline
7 December 2013